Novavax (WBO:NVAX) Land And Improvements : €0 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Novavax Land And Improvements?

Novavax's land and improvements for the quarter that ended in Mar. 2025 was €0 Mil.

Novavax's quarterly land and improvements increased from Sep. 2024 (€0 Mil) to Dec. 2024 (€14 Mil) but then declined from Dec. 2024 (€14 Mil) to Mar. 2025 (€0 Mil).

Novavax's annual land and improvements declined from Dec. 2022 (€96 Mil) to Dec. 2023 (€94 Mil) and declined from Dec. 2023 (€94 Mil) to Dec. 2024 (€14 Mil).

Novavax Land And Improvements Historical Data

The historical data trend for Novavax's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novavax Land And Improvements Chart

Novavax Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Land And Improvements

Get a 7-Day Free Trial

65.02

73.93

95.67

94.37

14.27

Novavax Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Land And Improvements	Get a 7-Day Free Trial															-	-	-	14.27	-

Novavax Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Novavax Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novavax Inc (WBO:NVAX) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

NVAX:USA NVAX:Mexico NVV1:Germany NVV1:Germany NVV1:Germany NVV1:Bulgaria

Address

700 Quince Orchard Road, Gaithersburg, MD, USA, 20878

Website

https://www.novavax.com

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.